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Abstract
Nanoparticles introduced in living cells are capable of strongly promoting the aggregation of peptides and proteins. We use
here molecular dynamics simulations to characterise in detail the process by which nanoparticle surfaces catalyse the self-
assembly of peptides into fibrillar structures. The simulation of a system of hundreds of peptides over the millisecond
timescale enables us to show that the mechanism of aggregation involves a first phase in which small structurally
disordered oligomers assemble onto the nanoparticle and a second phase in which they evolve into highly ordered b-sheets
as their size increases.
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Introduction
With the advent of nanoscience much interest has arisen about
the ways in which nanoparticles interact with biological systems,
because oftheirpotential applications innanotechnologyandeffects
on human health [1–7]. When nanoparticles are introduced in a
living organism they may interact with a variety of different cellular
components with yet largely unknown pathological consequences.
These concerns have been articulated particularly in the case of
misfolding disorders with increasing evidence, for example, about
an association between exposure to heavy metals and an enhanced
risk of developing Parkinson’s disease [8]. Such misfolding diseases
are caused by the aberrant association of peptides and proteins [9],
which result in fibrillar aggregates that share a common cross-b
structure of intertwined layers of b-sheets [9]. Although is well
known that such aggregates are formed in a nucleation-dependent
manner [9,10] and that very often nucleation phenomena are
known to be triggered by external factors [11], experimental reports
onprotein aggregation inheterogeneoussystemshave onlybegunto
emerge [12–15]. These studies are important, since peptides and
proteins in vivo often interact with a variety of potential seeding
agents such as macromolecular complexes or membranes, which
may strongly influence their aggregation behaviour. Indeed, it is
well known that colloids [12,14,15], lipid bilayers [16], and liquid-
air, liquid-solid or liquid-liquid interfaces [17,18] can have
significant effects in promoting amyloid formation. It has also been
recently shown that, in vivo, nanoparticles are often covered by
peptides and proteins that determine their behaviour in the cell
[13,15]. Despite these observations, the detailed processes under-
lying the association of proteins on surfaces or nanoparticles have so
far remained elusive.
In this work we use molecular dynamics simulations to
investigate the molecular mechanism of peptide self-assembly in
the presence of spherical nanoparticles. Although computational
studies using full atomistic models have provided considerable
insight into the role of fundamental forces in promoting the self-
assembly of polypeptide chains, they are restricted to relatively
small systems of peptides and short timescales [19–29]. Coarse-
grained models have proven capable of following the evolution of
systems composed of larger numbers of peptides over longer
timescales. The most tractable models are confined to a lattice
[30–32], although in these cases the structural details used to
represent polypeptide chain conformations are necessarily limited.
Off-lattice protein models used to simulate protein aggregation
include two-state models in which the protein can adopt, in
addition to a native state, a state that is prone to b-sheet formation
[33,34], two-bead models, in which each amino acid is represented
by two spheres with a knowledge-based potential [35], and fine-
grained models with explicit representation of the side chains in
combination with a phenomenological force field [36–39]. The
more detailed is the protein model, the higher is the computational
cost and the larger is the number of parameters required to specify
the force field [40]. The studies mentioned above have
investigated the process of protein self-assembly in homogeneous
systems in which external factors such as nanoparticles or other
molecules are absent. Only very recently, Friedman et al.
investigated the process of assembly of amphiphatic peptides in
the presence of lipid vescicles [41].
In the present work, we adopted an off-lattice protein model
[42–45], in which the protein backbone is represented as tube that
embeds a chain of Ca atoms subject to interactions that are
common to all polypeptide chains, including excluded volume
constraints, hydrophobic attractions, bending rigidity, and coop-
erative hydrogen bonds (see Materials and Methods). The major
strength of the model is its ability to reproduce rather accurately
secondary structure elements through the excluded-volume effects
PLoS Computational Biology | www.ploscompbiol.org 1 August 2009 | Volume 5 | Issue 8 | e1000458due to the tube geometry [42–45], which enables the use of a
relatively simple force field and thus is very efficient computation-
ally. By using this type of model, we already provided insight into
the early stages of the aggregation process, to establish the
existence of a general condensation-ordering transition for protein
aggregation [46,47], and to reveal a self-templated nucleation
mechanism [48] that is able to explain a key feature observed in
protein aggregation - the coupling between the initial formation of
oligomeric assemblies and their subsequent rearrangement into a
highly ordered cross-b structures. In this work, we show the
feasibility of simulating hundreds of peptides over several
milliseconds, and we characterise in detail the molecular
mechanism of self-assembly of the peptides at the surface of
nanoparticles. This process takes place in two steps - at first the
peptides associate on the surface thus increasing their local
concentration and subsequently they undergo a process of
reordering into b sheet structures, which is driven by the tendency
to form hydrogen bonds.
Results and Discussion
Starting from the experimental observation that amyloid
formation is a phenomenon common to most polypeptide chains
[9], and that systems of polyamino acids have been shown to form
amyloid assemblies [49,50], we investigate the aggregation
behaviour of 512 12-residue polyamino acids in the presence of
spherical nanoparticles (Fig. 1A) as a model system to reveal the
general properties of this phenomenon. The peptides that we
considered exhibit an a-helical native structure below their folding
temperature T 
f ~0:63 (expressed here in reduced units, see
Materials and Methods) and an extended random coil structure
above it. The aggregation behaviour that we observe depends on
the diameter s of the spherical nanoparticle and on the strength of
the peptide-nanoparticle interaction, eHP,S, which is the energy
gained when the distance between a Ca atom representing the
peptide molecules and the nanoparticle surface is smaller than
Author Summary
Protein misfolding and aggregation are associated with a
wide variety of human disorders, which include Alzhei-
mer’s and Parkinson’s diseases and late onset diabetes. It
has been recently realised that the process of aggregation
may be triggered by the presence of nanoparticles. We use
here molecular dynamics simulations to characterise the
molecular mechanism by which such nanoparticles are
capable of enhancing the rate of formation of peptide
aggregates. Our findings indicate that nanoparticle sur-
faces act as a catalyst that increases the local concentra-
tion of peptides, thus facilitating their subsequent
assembly into stable fibrillar structures. The approach that
we present, in addition to providing a description of the
process of aggregation of peptides in the presence of
nanoparticles, will enable the study of the mechanism of
action of a variety of other potential aggregation-
promoting agents present in living organisms, including
lipid membranes and other cellular components.
Figure 1. Illustration of the ‘‘condensation-ordering’’ mechanism of peptide self-assembly in the presence of a hydrophobic
nanoparticle. (A) Initially, at t~3:9 microseconds, the peptides are in their monomeric state. (B) At intermediate times, t~0:195 milliseconds, small
oligomeric assemblies form on the nanoparticle surface. (C) At later times, t~0:78 milliseconds, these oligomers re-order into fibrillar structures as
their size increases. Peptides that do not form intermolecular hydrogen bonds are shown in blue, while peptides that form intermolecular hydrogen
bonds are assigned a random colour, which is the same for peptides that belong to the same b-sheet. Two peptides are defined as belonging to the
same cluster if their centres of mass distance is less than 5 A ˚. Two peptides are taken to participate within a b-sheet if they form more than four inter-
chain hydrogen bonds with each other. The spherical nanoparticle is displayed in orange in the centre of the simulation box; the diameter of the
peptides is slightly reduced for illustration purposes. Panels (B) and (C) show enlarged views of the nanoparticle-peptide system. The simulation was
performed at c~3:4mM, T =T 
f ~1:1, s~110s, and eHP,S=eHP~2.
doi:10.1371/journal.pcbi.1000458.g001
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hydrophobic inter-residue interaction, since both interactions are
effectively due to hydrophobic solvation effects.
We first performed molecular dynamics simulations at a peptide
concentration, c~3:4mM, and reduced temperature, T ~0:69,
at which in absence of the nanoparticle aggregation does not occur
on the timescale accessible to the simulation. At this temperature
most peptides are unfolded since T =T 
f ~1:1. The nanoparticle
diameter is set to s~110s and the interaction strength between
the nanoparticle and the peptides, eHP,S=eHP~2, is set to twice
the value of the hydrophobic attraction, eHP, between different Ca
atoms. The results of a representative molecular dynamics
trajectory in presence of this weakly hydrophobic nanoparticle
are shown in Fig. 1.
We consistently observe that the presence of this hydrophobic
nanoparticle effectively removes the lag-time prior to aggregation
(Fig. 2A, red line) by triggering the condensation of peptides on the
nanoparticle surface to initially form small disordered oligomers
(Fig. 1B), which re-order into b-sheets as their size increases
(Fig. 1C). Although dimers and trimers constantly form and
dissolve throughout the simulation (Fig. 2B), larger oligomers
appear only on the nanoparticle surface and at later times. For
example, at t~0:195 milliseconds, we observed one cluster of size
n~7 in solution, and two clusters of sizes n~7 and n~12 on the
nanoparticle surface (see Figs. 1B, 2B, middle panel). At the end of
the simulation, at t~0:78 milliseconds, the two oligomers on the
nanoparticle surface had grown to sizes n~36 and n~42, whereas
the oligomers in solution dissolved (see Fig. 2B, right panel).
Animations representing the molecular dynamics trajectory
corresponding to Fig. 1 (Videos S1 and S2, Supplementary
Material) also illustrate that the small oligomers on the seed surface
can diffuse rather freely, and that two of them collide and merge
into a larger one.
In order to provide a detailed analysis of the structure of the
clusters that form on the nanoparticle surface we calculated the
liquid crystalline order parameter S~S3cos2 (h){1=2T,a
measure for the alignment between different strands in a single
b-sheet and between different b-sheets, where h is the angle
between neighbouring peptides within an aggregating cluster. Our
calculations confirm that small clusters are disordered and only
larger ones reach a value S^0:8 characteristic for liquid
crystalline ordering (Fig. 2C). To investigate the effect of the
nanoparticle on the local structure around its surface we calculated
the density profile of peptides as a function of their distance from
the centre of mass of the nanoparticle. Our results illustrate that
the presence of a hydrophobic nanoparticle leads to the formation
Figure 2. Structural analysis of the nanoparticle-induced self-assembly mechanism. (A) Average size of the largest cluster n  observed
during a simulation in presence of a hard sphere nanoparticle: s~110s, eHP,S~0 (green line), and several hydrophobic nanoparticles that differ in
diameter and hydrophobicity: s~110s, eHP,S=eHP~1 (blue line), s~110s, eHP,S=eHP~2 (red line), and s~65s, eHP,S=eHP~2 (black line). The
results are averaged over ten independent simulation runs and the error bars correspond to the standard deviation of the mean. (B) Number of
clusters Nn of size n as a function of time: t~3:9 microseconds (left), t~0:195 milliseconds (middle), t~0:78 milliseconds (right), for the MD trajectory
and parameters described in Fig. 1. Black lines correspond to all clusters formed in the system; red lines correspond to the number of clusters formed
on the nanoparticle surface. (C) Structural order parameter S as a function of the cluster size n averaged over ten independent simulations. The line
colours are as described in (A). (D) Normalized density profile g(r)=g0, where g0 is the bulk density of the system, as a function of the distance from
the centre of mass of the nanoparticle at the beginning of the simulation, t~3:9 microseconds (left panel), intermediate times, t~0:195 milliseconds
(middle panel), and at the end t~0:78 milliseconds (right panel). The different line colours are as described in (A) and correspond to the different
seed sizes and peptide seed interaction energies. The results are averaged over ten independent simulations and the error bars correspond to the
standard deviation of the mean.
doi:10.1371/journal.pcbi.1000458.g002
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more pronounced as the simulation progresses (Fig. 2D). The
enhanced density of peptides at the nanoparticle surface increases
the probability to form clusters, which will eventually trigger the
formation of small clusters on the seed surface. The appearance of
a double layer structure seems to be dependent on the reaching of
a local density threshold (compare different curves in 2D,
rightmost panel). The facilitation of the nucleation step within
an intermediate dense assembly is well known in crystallisation
[51] and was also observed in the assembly of peptides into cross-b
structures [47]. These results also provide a molecular illustration
of the dynamics of polypeptide chains associated with the
‘‘corona’’ effect observed in recent experiments [13,15], which
has revealed that in vivo nanoparticles are always covered by
biological molecules.
In our simulations the lag time for nanoparticle induced peptide
aggregation is about a microsecond which is quite short compared
to the lag times typically observed in experiments. The latter range
from some hours to several days, but it should be noted that both
peptide concentration (3.4 mM) and, especially, nanoparticle
concentration (6.5 mM) are much higher than in experiments
(40–80 mM and 4–90 pM, respectively) [12]. This implies that in
our simulations nucleation barriers are essentially removed by the
nanoparticle whereas in experiments they are still high.
In our model system the binding of peptides to the nanoparticle
is stronger for the more hydrophobic surface (Fig. 2D). As a result,
increasing the hydrophobicity of the nanoparticle reduces the lag
time prior to aggregation (Figs. 2A and 3). The same correlation
between a stronger nanoparticle-protein binding and a more
enhanced reduction of the lag time prior to aggregation is found in
experiments on b2-microglobulin fibrillation in the presence of
hydrophobic copolymer nanoparticles [12]. This supports the
already suggested notion that a hydrophobic nanoparticle favors
aggregation by leading to a local increase in peptide concentration
around its surface. Note that, as b2-microglobulin is found to bind
more weakly to the more hydrophobic nanoparticles, the latter are
found to be less effective as well in reducing aggregation lag times
[12]. Both these facts are not reproduced in our simulations,
reflecting our most simple modeling of the hydrophobic effect and
of the internal structure of both the nanoparticle and the protein.
We did not observe an increase of the lag time prior to
aggregation by using a smaller nanoparticle diameter, s~60s.
The fluctuations in the size of the largest cluster are nevertheless
larger, indicating that the bigger nanoparticle is a slightly more
efficient seed. Experimentally, it was shown that curvature effects
can strongly affect the fibrillation kinetics in a way which depends
on solution conditions [12]. In our simulations we simply cannot
observe this effect because the nucleation barriers are effectively
removed by the nanoparticle.
As a final remark, we observe that the molecular mechanism
associated with the condensation ordering transition for peptide
nanoparticle association described here is independent of particle
size and hydrophobicity. The structural reorganization of protein
chains in the early disordered oligomeric assemblies from their
native or unstructured conformation to the cross-b state may be
more easily observed by experiments using a nanoparticle as it
localizes the nucleation event, which may enable to monitor the
reorganization process by fluorescence methods.
Conclusions
We have characterised the process of nanoparticle-catalysed
peptide aggregation in terms of a condensation-ordering mecha-
nism and investigated its dependence on the nanoparticle diameter
and the strength of the nanoparticle-peptide interactions. A similar
mechanismofaggregationhas alreadybeen observed intheabsence
of catalysing factors [46–48,52], suggesting that the process of
aggregation is driven in both cases by the intrinsic tendency of
polypeptide chains to associate by forming ordered networks of
Figure 3. Illustration of the condensation-ordering mechanism for different hydrophobicity of the nanoparticle, nanoparticle
diameter. (A) s~110s, eHP,S=eHP~1 at t~3:9 microseconds(left), t~0:165 milliseconds (middle), t~0:78 milliseconds (right). (B) s~65s,
eHP,S=eHP~2 at t~3:9 microseconds (left), t~0:195 milliseconds (middle), t~0:78 milliseconds (right). The concentration and temperature are
c~3:4mM, T =T 
f ~1:1 respectively, and the colour code is as described in Fig 1.
doi:10.1371/journal.pcbi.1000458.g003
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initial condensation of peptides is initiated by nanoparticle surfaces
to form small disordered oligomeric structures that subsequently re-
order into b-sheets as their size increases. Although this mechanism
will be modulated by specific sequence-dependent interactions for
more complex amino acid sequences, our findings are consistent
with recent experiments on seeded fibrillation [12]. These results
therefore suggest that the process of protein aggregation can be
speeded up by the presence of factors capable of increasing the local
concentration of proteins and thus promoting the formation of
disorder oligomeric assemblies whose presence in turn facilitates the
conversion of soluble proteins into highly ordered fibrillar
structures.
Materials and Methods
Description of the model
We used a modified version of the tube model [42]. In this
model, residues are represented by their Ca atoms, which are
connected into a chain with a distance of 3.860.2 A ˚ between
neighbouring atoms. The tube geometry is approximated by
assigning a diameter of 3.8 A ˚ to the Ca atoms. Neighbouring Ca
atoms are not allowed to interpenetrate. Bond angles are restricted
between 82u to 148u, and an analogue of bending rigidity is
introduced by means of an energetic penalty, eSw0, for values of
bond angles lower than 107.15u; these are the same criteria used
previously [42]. The introduction of eS is useful to mimic the
constraints placed on local conformations by the presence of side
chains, as usually visualised by Ramachandran plot. Hydropho-
bicity enters through a pairwise-additive interaction energy of eHP
(positive or negative) between any pair of residues i and jwiz2
that approach closer than 7.5 A ˚.
The quasi-cylindrical symmetry of the tube is broken by the
geometric requirements of hydrogen bonds. These geometrical
requirements were deduced from an analysis of 500 high resolution
PDBnativestructures[55],fromwhichwecomputedthenormalised
histograms of distances between Ca atoms involved in backbone-
backbone hydrogen bonds which are shown in Fig. 4. The distances
we used to define the hydrogen bonds at the Ca atom level are
summarised in Table 1. Our definitions distinguish between
hydrogen bonds that belong to a a helix, parallel or anti-parallel b
sheets. We emphasise the fact that there is not a full correspondence
with the real hydrogen bonds formed between amide and carboxyl
backbone groups. For instance, there are two different kinds of
residue pairs facing each other in nearby anti-parallel b-strands. In
the first kind, the two hydrogen bonds are formed between the two
residues, whereas in the second kind, no hydrogen bond is formed
between them. The two kinds alternate along the pair of nearby
strands. In our definition of hydrogen bonds based on Ca atoms, we
will say that for both kind of pairs one hydrogen bond is formed
between the two Ca
0s. Yet, we keep track of the peculiar geometry of
hydrogen bonds within anti-parallel b-sheets by using two different
sets of distances, which we call anti-parallel 1 and anti-parallel 2, as
the distances between consecutive Ca pairs facing each other on
nearby b-strands do indeed alternate. Furthermore, we request that
one residue cannot form more than two hydrogen bonds, and that
the first and last Ca atomsofa peptide do not at all. Hydrogen bonds
may form cooperatively between residues (i,j) and (iz1,jz1) [or
(i,j) and (iz1,j{1) for anti-parallel hydrogen bonds], thereby
gaining an additional energy of 0:3eHB. The distance criteria for
Figure 4. Normalised histograms of distances between Ca atoms involved in backbone-backbone hydrogen bonds. The analysis is
based on 500 high resolution PDB structures [55] and used to define hydrogen bonds in the protein model employed in our simulation. (A) Histogram
of distances di,j{1 and di{1,j between Ca atoms (i,j{1) and (i{1,j) used to define a a helical hydrogen bond assigned to atoms (i,j) with j~iz3. (B)
Histogram of distances di,j between Ca atoms (i,j) that form a parallel, anti-parallel, or helical hydrogen bond. For the a helical hydrogen bond
j~iz3. (C) Illustration of the alternation of distances for consecutive Ca atoms that form anti-parallel hydrogen bonds. (D) as in (C). (E) The distance
di,j{1 is used to define hydrogen bonds between atoms (i,j) in parallel and anti parallel b-sheets. (F) Distances used to define cooperative hydrogen
bonds between two consecutive atoms (i,j) and (iz1,jz1) that form parallel b-sheets or (i,j) and (iz1,j{1) that form anti parallel b-sheets.
doi:10.1371/journal.pcbi.1000458.g004
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Fig. 4F and summarised in Table 1.
The energy of hydrogen bonds was set to eHB~{3kTo, where
kTo is the thermal energy at room temperature and k is the
Boltzmann constant. This energy correspond to the experimental
one (1.5 kCal/mol at room temperature [56]). Values of the
hydrophobicity and stiffness parameters, eHP and eS, are given in
units of kTo and the reduced temperature is T ~T=To. In all our
simulations we set eS~0:9kTo and eHP~{0:15kTo. The ratio of
a hydrogen bonding energy to hydrophobic energy is
eHB=eHP~20. As the number of hydrophobic contacts within an
oligomer is usually about one order of magnitude larger than the
number of hydrogen bonds, our choice ensures that these
interactions provide similar contributions to the potential energy
of the oligomer [47]. For this set of model parameter the peptide
folds into a native a-helical state below the folding temperature
T 
f ~0:63. eHP,S is the parameter which determines the strength of
the interaction energy between Ca atoms representing the peptide
molecules and the seed particle. The range of the peptide seed
interaction is set to 10 A ˚ from the nanoparticle surface.
Simulation techniques
We performed discontinuous molecular dynamics (DMD)
simulations [57], which is a fast alternative to standard molecular
dynamics simulations. The main difference is that in DMD
simulations the system evolves on a collision by collision basis,
and requires the calculation of the collisiondynamicsand the search
for the next collision. In the simulations we used a cubic box, of side
633 A ˚, and applied periodic boundary conditions. The implemen-
tation of our definition for the hydrogen bonding requires some
additional consideration. In order to prevent that one residue forms
three hydrogen bonds we treat the associated collision as fully
elastic. In order to implement and consider cooperative hydrogen
bonding we keep and update a list of all hydrogen bonds formed in
the system at all times. Note that a recalculation of the hydrogen
bondsformedinthesystemwithoutconsideringthislistcanleadtoa
different result. Independent starting configurations were generated
at T ~0:75 and rapidly cooled down to T ~0:69 at the beginning
of each simulation run. We performed all our simulation in the
NVT ensemble using an Anderson thermostat.
In order to associate the number of collision steps performed in
oursimulationtoa real time wemeasured the long time self-diffusion
coefficient of our model peptide, Dpep~0:0085s
2
= collision step ðÞ ,
and matched ittoexperimentaldata.Wetook from theliteraturethe
value for the self-diffusion coefficient, Dlys~13:7|10{7cm2
sec,
which was measured for lysozyme [43]. The Einstein relation for the
diffusion coefficient together with the Stokes law yield
D~kBT=6pgr where KB is the Boltzmann constant, r is the radius
of the diffusing object, and g is the viscosity. The latter can be
evaluated through kinetic theory as g*nkBTt,w h e r en is the
density of the viscous medium in which diffusion takes place and t is
the mean flight time between collision with solvent molecules setting
the time scale [15]. The resulting expression for the diffusion
coefficient D*1=nrt allows us to get
tlys
tpep
~
Dpeprpep
Dlysrlys
^0:195
picoseconds as an estimate of the real time corresponding to one
collision step in our molecular dynamics simulations. We use
rlys~19s as an estimate of r for lysozyme, whereas we take
rpep~5:85s asthe averageradiusofgyration ofthe peptide asfound
inour simulations.Hence, the totalnumberofcollision steps, 4610
9,
performed in every simulation corresponds qualitatively to 0.78 mil-
liseconds.
Supporting Information
Video S1 Configurations obtained from the molecular dynamics
trajectory that corresponds to Fig. 1.
Found at: doi:10.1371/journal.pcbi.1000458.s001 (5.47 MB
MPG)
Video S2 Final configuration obtained from the molecular
dynamics trajectory shown to Fig. 1.
Found at: doi:10.1371/journal.pcbi.1000458.s002 (3.25 MB
MPG)
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